RFG Bristol Wealth Advisors LLC Buys 4,509 Shares of AMETEK, Inc. $AME

Key Points

• RFG Bristol Wealth Advisors increased its AMETEK stake by 78.2% in the third quarter, purchasing 4,509 additional shares and bringing its holdings to 10,277 shares valued at approximately $2.55 million. Institutional investors collectively own 87.43% of the company.
• AMETEK exceeded quarterly expectations, reporting $2.09 EPS and $2.04 billion in revenue, with revenue up 15% year over year. The company also maintains 2026 guidance of $8.20–$8.30 EPS and pays a $0.34 quarterly dividend.
• Analyst sentiment remains positive, with a consensus “Moderate Buy” rating and an average price target of $268.88 versus a recent share price of $248.55. However, the stock trades near its 52-week high at roughly 36 times earnings, suggesting some optimism may already be priced in.

RFG Bristol Wealth Advisors LLC raised its stake in shares of AMETEK, Inc. (NYSE:AME - Free Report) by 78.2% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 10,277 shares of the technology company's stock after buying an additional 4,509 shares during the period. RFG Bristol Wealth Advisors LLC's holdings in AMETEK were worth $2,546,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the stock. GK Wealth Management LLC purchased a new stake in shares of AMETEK in the third quarter worth about $36,000. Balefire LLC purchased a new position in AMETEK during the third quarter valued at approximately $209,000. Riversedge Advisors LLC lifted its holdings in AMETEK by 154.1% in the third quarter. Riversedge Advisors LLC now owns 5,315 shares of the technology company's stock valued at $1,317,000 after acquiring an additional 3,223 shares during the period. Wedmont Private Capital lifted its holdings in AMETEK by 159.5% in the third quarter. Wedmont Private Capital now owns 9,559 shares of the technology company's stock valued at $2,368,000 after acquiring an additional 5,875 shares during the period. Finally, LifeGoal Investments LLC purchased a new stake in AMETEK in the 3rd quarter worth approximately $259,000. Institutional investors and hedge funds own 87.43% of the company's stock.

AMETEK Price Performance

Shares of AME stock traded up $1.03 during trading hours on Friday, hitting $248.55. 854,341 shares of the company's stock were exchanged, compared to its average volume of 1,306,110. The company has a quick ratio of 0.76, a current ratio of 1.21 and a debt-to-equity ratio of 0.09. The firm has a market cap of $56.97 billion, a P/E ratio of 36.34, a P/E/G ratio of 2.35 and a beta of 0.96. The firm has a 50 day moving average of $244.83 and a two-hundred day moving average of $235.49. AMETEK, Inc. has a fifty-two week low of $179.24 and a fifty-two week high of $261.16.

AMETEK (NYSE:AME - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The technology company reported $2.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.99 by $0.10. The firm had revenue of $2.04 billion for the quarter, compared to analysts' expectations of $1.95 billion. AMETEK had a net margin of 20.04% and a return on equity of 16.93%. The firm's revenue for the quarter was up 15.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.78 EPS. AMETEK has set its Q3 2026 guidance at 2.080-2.100 EPS and its FY 2026 guidance at 8.200-8.300 EPS. Sell-side analysts forecast that AMETEK, Inc. will post 8.42 EPS for the current year.

AMETEK Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th were given a $0.34 dividend. The ex-dividend date was Tuesday, September 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.5%. AMETEK's dividend payout ratio (DPR) is 19.88%.

Insider Activity at AMETEK

In other news, insider David Hermance sold 6,608 shares of the business's stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $254.00, for a total transaction of $1,678,432.00. Following the completion of the sale, the insider owned 42,509 shares of the company's stock, valued at $10,797,286. The trade was a 13.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.54% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on AME. Morgan Stanley set a $275.00 target price on shares of AMETEK in a report on Friday. Zacks Research raised shares of AMETEK from a "hold" rating to a "strong-buy" rating in a report on Tuesday. TD Cowen restated a "buy" rating on shares of AMETEK in a research report on Thursday, August 6th. Citigroup lifted their price objective on shares of AMETEK from $257.00 to $261.00 and gave the company a "neutral" rating in a report on Wednesday, August 5th. Finally, KeyCorp upped their price objective on shares of AMETEK from $260.00 to $295.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 5th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat, AMETEK currently has a consensus rating of "Moderate Buy" and a consensus price target of $268.88.

Trending Headlines about AMETEK

Here are the key news stories impacting AMETEK this week:

• Positive Sentiment: Morgan Stanley raised its price target to $275 from $245, implying additional upside from recent trading levels and signaling increased confidence in AMETEK’s outlook. Morgan Stanley Adjusts Price Target on AMETEK to $275 From $245
• Positive Sentiment: Zacks Research upgraded AMETEK from Hold to Strong Buy and raised its estimates across multiple periods. Its forecasts increased to $8.40 EPS for fiscal 2026, $9.58 for fiscal 2027, and $10.66 for fiscal 2028, compared with previous estimates of $8.27, $8.74, and $9.33, respectively. AMETEK Upgraded to Strong-Buy at Zacks Research
• Positive Sentiment: Zacks also lifted quarterly EPS estimates, including Q3 2026 to $2.11 from $2.08, Q4 2026 to $2.23 from $2.13, Q1 2027 to $2.23 from $2.09, and Q3 2027 to $2.46 from $2.19. The increases suggest improving expectations for near- and longer-term operating performance.
• Positive Sentiment: A Zacks analysis identified AMETEK’s strong earnings-surprise history and favorable setup for another quarterly beat, potentially supporting investor optimism ahead of the next report. Why AMETEK Could Beat Earnings Estimates Again
• Neutral Sentiment: AMETEK is trading near its 12-month high and at roughly 36 times earnings, so the positive analyst revisions may already be partly reflected in the valuation. Continued upside could depend on the company meeting or exceeding its current guidance and consensus expectations.

AMETEK Company Profile

AMETEK, Inc NYSE: AME is a global manufacturer of industrial technology products. The company develops and produces electronic instruments and electromechanical devices used in process, industrial, aerospace, power, energy, and other specialized markets.

AMETEK's Electronic Instruments segment supplies products such as process and analytical instruments, measurement and testing equipment, power-quality monitoring systems, automation and control solutions, and equipment for aerospace and defense applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.